北美碳疗法市场预测至 2028 年 – COVID-19 影响和区域分析 – 按类型(台式、便携式等)、应用[美容医学(橘皮组织、妊娠纹、脱发和黑眼圈) 、皮肤科、妇科、血管科、骨科和风湿科、运动医学等]和最终用户(医院、美容诊所和健康中心)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 92    |    Report Code: BMIRE00027998    |    Category: Life Sciences

North America Carboxy Therapy Market

北美羧基治疗市场预计将从2022年的3635万美元增长到2028年的7269万美元。预计2022年至2028年复合年增长率为12.2% .

 

老年人口激增和抗衰老治疗需求不断增加正在推动北美羧基治疗市场

 

65岁或以上的人的频率可能会从2019年的十分之一增加到2025年的六分之一。据世界卫生组织估计,到2050年,60岁及以上人口的比例预计将从2015年的12%增至22%。因此,老年人口的显着增加和地区层面美容标准的变化增加了对老年人口的需求。抗衰老治疗可减少细纹和皱纹,有助于长期保持年轻肌肤。衰老是一个不可避免的现象。人们对美学的认识不断增强,极大地刺激了抗衰老治疗的需求。此外,老年人口的增加产生了对各种类型的抗衰老和嫩肤治疗的需求。羧基疗法可确保营养物质的最大吸收并提供健康的皮肤。此外,随着可支配收入的激增,大量人群对个性和外表的认识不断提高,这增加了美容治疗的使用,有助于北美羧基疗法市场的增长。

 

北美概览

 

北美羧基疗法的市场包括美国、加拿大和墨西哥。由于抗衰老治疗需求增加和无创美容手术激增等多种因素,北美羧基疗法市场在2021年占据了最大的市场份额。此外,美容手术需求的增加和老年人口的不断增加也推动了市场的发展。此外,羧基疗法应用领域的增加可能会在未来几年创造充足的机会。根据 ASAPS 2020,2020 年记录了 1560 万例整容手术,其中包括约 230 万例整容手术和 1320 万例整容微创手术。此外,根据国际美容整形外科学会的报告,2020年美国进行了174,300例光子嫩肤手术。此外,羧基疗法在神经病学、妇科和泌尿科等医学领域的应用不断增加,预计将大大促进羧基疗法市场的增长。因此,美容手术数量的增加和支出的增加可能会支持市场增长,并预计在预测期内带来充足的收入增长。

 

< span>

北美羧基治疗市场收入及 2028 年预测(百万美元)

北美羧基治疗市场细分

北美羧基治疗市场细分为类型、应用、最终用户和国家/地区。

 

根据类型,北美羧基治疗市场分为台式、便携式、和别的。预计到 2022 年,台式细分市场将占据最大的市场份额。

 

根据应用,北美羧基治疗市场细分为美容医学、皮肤科、血管科、妇科、骨科和风湿科、运动医学等。预计到 2022 年,美容医学领域将占据最大的市场份额。美容医学领域进一步细分为脂肪团、妊娠纹、脱发和黑眼圈。

  ;

根据最终用户,北美羧基疗法市场分为医院、美容诊所和健康中心。预计到 2022 年,医院细分市场将占据最大的市场份额。

 

根据国家/地区,北美羧基治疗市场细分为美国、加拿大和墨西哥。 2022 年,美国将占据市场份额。

 

Carbossiterapia Italiana; DTA 医疗;卡斯特纳-普拉西斯贝达夫; MBE 医疗部门;梅佐制药;和 Nick Fanavaran Plasma Company 是北美羧基治疗市场的领先公司之一。



North America Carboxy Therapy Strategic Insights

Strategic insights for North America Carboxy Therapy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-carboxy-therapy-market-strategic-framework.webp
Get more information on this report

North America Carboxy Therapy Report Scope

Report Attribute Details
Market size in 2022 US$ 36.35 Million
Market Size by 2028 US$ 72.69 Million
Global CAGR (2022 - 2028) 12.2%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 类型
  • 台式
  • 便携式
By 应用
  • 美容医学
By 最终用户
  • 医院
  • 美容诊所
  • 健康中心
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Carbossiterapia Italiana
  • DTA Medical
  • Kastner-Praxisbedarf
  • MBE Medical Division
  • Mezopharma
  • NickFanavaran Plasma Company
  • Get more information on this report

    North America Carboxy Therapy Regional Insights

    The regional scope of North America Carboxy Therapy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-carboxy-therapy-market-geography.webp
    Get more information on this report

    The List of Companies - North America Carboxy Therapy Market

    1. Carbossiterapia Italiana
    2. DTA Medical
    3. Kastner-Praxisbedarf
    4. MBE Medical Division
    5. Mezopharma
    6. Nick Fanavaran Plasma Company
    Frequently Asked Questions
    How big is the North America Carboxy Therapy Market?

    The North America Carboxy Therapy Market is valued at US$ 36.35 Million in 2022, it is projected to reach US$ 72.69 Million by 2028.

    What is the CAGR for North America Carboxy Therapy Market by (2022 - 2028)?

    As per our report North America Carboxy Therapy Market, the market size is valued at US$ 36.35 Million in 2022, projecting it to reach US$ 72.69 Million by 2028. This translates to a CAGR of approximately 12.2% during the forecast period.

    What segments are covered in this report?

    The North America Carboxy Therapy Market report typically cover these key segments-

  • 类型 (台式, 便携式)
  • 应用 (美容医学)
  • 最终用户 (医院, 美容诊所, 健康中心)
  • What is the historic period, base year, and forecast period taken for North America Carboxy Therapy Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Carboxy Therapy Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in North America Carboxy Therapy Market?

    The North America Carboxy Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Carbossiterapia Italiana
  • DTA Medical
  • Kastner-Praxisbedarf
  • MBE Medical Division
  • Mezopharma
  • NickFanavaran Plasma Company
  • Who should buy this report?

    The North America Carboxy Therapy Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Carboxy Therapy Market value chain can benefit from the information contained in a comprehensive market report.